Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-2-23
pubmed:abstractText
Recent studies have indicated that caveolae are enriched in a variety of signaling molecules, some of which are associated with cardiomyocyte hypertrophy. Caveolin-3, a major constituent of cardiac caveolae, has been suggested to interact with several signaling molecules. We investigated the morphologic changes of caveolae and caveolin-3 expression in hypertrophied cardiomyocytes induced by an alpha1-adrenergic agonist. Cultured rat neonatal cardiomyocytes were used for the experiments. Phenylephrine induced cellular hypertrophy associated with an increase of the number of caveolae and an up-regulation of caveolin-3. Although PMA increased the number of caveolae and the caveolin-3 expression, the extent of these up-regulations was less than that by phenylephrine. Moreover, ionomycin increased the number of caveolae and up-regulated caveolin-3 as much as phenylephrine. Phenylephrine-induced up-regulations of caveolae and caveolin-3 expression were inhibited by BAPTA, suggesting that the intracellular Ca2+ is involved in those regulations. Inhibitors of calcineurin and Ca2+calmodulin-dependent kinase II attenuated the phenylephrine-induced up-regulation of caveolin-3. In pressure-overloaded rat hearts, caveolin-3 protein levels were increased compared with sham-operated rats. In conclusion, the number of caveolae and the expression of caveolin-3 were up-regulated in rat hypertrophied cardiomyocytes, possibly via the alterations of intracellular Ca2+ and protein kinase C.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0160-2446
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
204-10
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15725944-Adrenergic alpha-1 Receptor Agonists, pubmed-meshheading:15725944-Adrenergic alpha-Agonists, pubmed-meshheading:15725944-Animals, pubmed-meshheading:15725944-Animals, Newborn, pubmed-meshheading:15725944-Blotting, Northern, pubmed-meshheading:15725944-Cardiomegaly, pubmed-meshheading:15725944-Caveolae, pubmed-meshheading:15725944-Caveolin 3, pubmed-meshheading:15725944-Caveolins, pubmed-meshheading:15725944-Cell Size, pubmed-meshheading:15725944-Cells, Cultured, pubmed-meshheading:15725944-Immunoblotting, pubmed-meshheading:15725944-Leucine, pubmed-meshheading:15725944-Male, pubmed-meshheading:15725944-Microscopy, Electron, pubmed-meshheading:15725944-Myocytes, Cardiac, pubmed-meshheading:15725944-Phorbol 12,13-Dibutyrate, pubmed-meshheading:15725944-Rats, pubmed-meshheading:15725944-Rats, Wistar, pubmed-meshheading:15725944-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15725944-Up-Regulation
pubmed:year
2005
pubmed:articleTitle
Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy.
pubmed:affiliation
Department of Internal Medicine III and Cardiovascular Research Institute, Kurume University School of Medicine, Kurume, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't